Tamayo, Aimie .
HRN: 23-61-00 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2025
AMPICILLIN 1GM (VIAL)
12/09/2025
12/11/2025
IVT
2g
Q6
Prom
Checking Final Appropriateness
12/09/2025
CEFUROXIME 1.5GM (VIAL)
12/09/2025
12/09/2025
IV
1.5g
PTOR
Cs For Nrfht
Checking Final Appropriateness
12/09/2025
CEFUROXIME 1.5GM (VIAL)
12/09/2025
12/10/2025
IV
1.5g
Q8
S/p CS
Checking Final Appropriateness
12/10/2025
CEFUROXIME 500MG (TAB)
12/10/2025
12/17/2025
PO
500mg
BID
S/P PLTCS
Checking Final Appropriateness